Quality of Life Measurement for Lymphedema Patients

• Conditions: I89.01; I89.02; I89.03

• Registration Number: DRKS00034664
• Lead Sponsor: niklinikum Leipzig

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-03-16
• Study Start: 2024-07-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 273

Inclusion Criteria

Medically diagnosed lymphedema and the participant's ability to provide. Informed consent.

Exclusion Criteria

Missing consent.
No medically diagnosed lymphedema.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
gender, primary or secondary cause, the affected side, employment status, educational attainment, smoking status, ISL stage, age, the time between diagnosis and interview, and BMI<br>

Secondary Outcome Measures

Name	Time	Method
YMQOL Questionnaire<br>Function - subscale<br>Appearance- subscale<br>Symptoms- subscale<br>Mood- subscale<br>LYMQOL score<br><br>SF-36 Questionnaire:<br>General health (GH)- subscale<br>Physical function (PF)- subscale<br>Role physical (RP)- subscale<br>Role emotional (RE)- subscale<br>Vitality (VT) - subscale<br>Mental health (MH) - subscale<br>Social functioning (SF) - subscale<br>Bodily pain (BP) - subscale<br>